Mar Buendía

3.6k total citations
13 papers, 297 citations indexed

About

Mar Buendía is a scholar working on Physiology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mar Buendía has authored 13 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Psychiatry and Mental health and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mar Buendía's work include Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Mar Buendía is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Mar Buendía collaborates with scholars based in Spain, United States and Netherlands. Mar Buendía's co-authors include Merçé Boada, Lluís Tárraga, Asunción Lafuente, Montserrat Alegret, Agustı́n Ruiz, Pedro Pesini, Manuel Sarasa, Virginia Pérez‐Grijalba, Isabel Hernández and Inmaculada Monleón and has published in prestigious journals such as PLoS ONE, Journal of Alzheimer s Disease and Alzheimer s & Dementia.

In The Last Decade

Mar Buendía

12 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mar Buendía Spain 7 223 91 81 66 59 13 297
Asunción Lafuente Spain 5 167 0.7× 60 0.7× 55 0.7× 48 0.7× 53 0.9× 7 220
Mireia Torres Spain 6 196 0.9× 66 0.7× 86 1.1× 60 0.9× 29 0.5× 10 295
Aleksandra Pastrak United States 8 188 0.8× 51 0.6× 99 1.2× 30 0.5× 93 1.6× 19 354
Carolyn Liebsack United States 8 212 1.0× 116 1.3× 42 0.5× 44 0.7× 23 0.4× 14 357
Conn Harrington United States 5 133 0.6× 33 0.4× 81 1.0× 47 0.7× 60 1.0× 10 266
Aikaterini Anastasiou Greece 6 113 0.5× 36 0.4× 66 0.8× 47 0.7× 46 0.8× 17 268
Kevin Booth United States 7 134 0.6× 36 0.4× 35 0.4× 36 0.5× 72 1.2× 17 192
Przemysław R. Kac Sweden 9 274 1.2× 190 2.1× 106 1.3× 69 1.0× 32 0.5× 19 446
Fernando González‐Ortiz Sweden 9 266 1.2× 182 2.0× 113 1.4× 71 1.1× 24 0.4× 34 458
Judith Romero Spain 4 146 0.7× 101 1.1× 62 0.8× 36 0.5× 14 0.2× 10 226

Countries citing papers authored by Mar Buendía

Since Specialization
Citations

This map shows the geographic impact of Mar Buendía's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mar Buendía with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mar Buendía more than expected).

Fields of papers citing papers by Mar Buendía

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mar Buendía. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mar Buendía. The network helps show where Mar Buendía may publish in the future.

Co-authorship network of co-authors of Mar Buendía

This figure shows the co-authorship network connecting the top 25 collaborators of Mar Buendía. A scholar is included among the top collaborators of Mar Buendía based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mar Buendía. Mar Buendía is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
3.
Abdelnour, Carla, Sergi Valero, Maitée Rosende‐Roca, et al.. (2020). Gender and sex bias in clinical trial recruitment in Alzheimer's disease: Findings from Fundació ACE. Alzheimer s & Dementia. 16(S10). 2 indexed citations
4.
Pérez‐Grijalba, Virginia, Javier Arbizu, Judith Romero, et al.. (2019). Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study. Alzheimer s Research & Therapy. 11(1). 96–96. 39 indexed citations
5.
Pascual‐Lucas, María, Pedro Pesini, Virginia Pérez‐Grijalba, et al.. (2018). Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial. Alzheimer s Research & Therapy. 10(1). 12–12. 81 indexed citations
6.
Boada, Merçé, Miguel Santos‐Santos, Octavio Rodríguez‐Gómez, et al.. (2018). Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer’s Disease Research. Journal of Alzheimer s Disease. 62(3). 1079–1090. 15 indexed citations
7.
Cuberas‐Borrós, Gemma, Isabel Bielsa, Merçé Boada, et al.. (2017). Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer’s Disease Patients Treated with Plasma Exchange with 5% Human Albumin. Journal of Alzheimer s Disease. 61(1). 321–332. 26 indexed citations
8.
9.
Sotolongo‐Grau, Óscar, Pedro Pesini, Sergi Valero, et al.. (2014). Association between cell-bound blood amyloid-β(1 - 40) levels and hippocampus volume. Alzheimer s Research & Therapy. 6(5-8). 56–56. 9 indexed citations
10.
11.
Bielsa, Isabel, Gemma Cuberas‐Borrós, Lluís Tárraga, et al.. (2012). P3‐403: Longitudinal neuroimaging analysis in Alzheimer's disease after plasma exchange with 5% Grifols albumin (Albutein®). Alzheimer s & Dementia. 8(4S_Part_16). 1 indexed citations
12.
Boada, Merçé, Laura Núñez, Isabel de la Torre Díez, et al.. (2011). P2‐448: Peripheral amyloid‐beta mobilization with the intravenous immunoglobulin Flebogamma DIF® in Alzheimer's disease patients. Alzheimer s & Dementia. 7(4S_Part_13). 5 indexed citations
13.
Boada, Merçé, et al.. (2008). The usefulness of standard neuropsychological testing for adults with Down syndrome and dementia. 12(1). 2–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asunción Lafuente Breakdown of academic impact, for papers by Mireia Torres Breakdown of academic impact, for papers by Aleksandra Pastrak Breakdown of academic impact, for papers by Carolyn Liebsack Breakdown of academic impact, for papers by Conn Harrington Breakdown of academic impact, for papers by Aikaterini Anastasiou Breakdown of academic impact, for papers by Kevin Booth Breakdown of academic impact, for papers by Przemysław R. Kac Breakdown of academic impact, for papers by Fernando González‐Ortiz Breakdown of academic impact, for papers by Judith Romero
Rankless by CCL
2026